NASDAQ NMS - GLOBAL MARKET · NRXP
0.00% · $0.0000 · Vol 947.3K
Market closed · last close 4:00 PM ET · price as of 19:49:22 ET
NRX Pharmaceuticals Inc

NRX Pharmaceuticals Inc

Pharmaceuticals
$3.39
Card
Relationship Map

Follow $NRXP

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $NRXP by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
NRXP
NRX Pharmaceuticals Inc
Sat Sep 19 · completed session · Markets closed · resumes Mon 9:30 ET
Lowest range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

24/ 100
Veridion Score
Lowest range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Sat Sep 19 · completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is NRXP moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading NRXP catalysts
About NRX Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
29
Country
US

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.38
Day high
$3.42
Day low
$3.31
Previous close
$3.39
52W high
$4.62
-26.62% from high
52W low
$1.68
58% of range
Market cap
$143.7M
EPS
$-0.4400
Beta
2.07
Shares out
43.3M
Volume
947.3K
0.96× rel vol
Avg volume
982.4K
VWAP
$3.34
Price history computed in-house
1W
-0.29%
1M
-4.78%
3M
-13.08%
1Y
+14.14%
YTD
+25.09%
SMA 50 $3.58 · below
SMA 200 $2.90 · above
52W position 58%

NRXP overview

Veridion Score
24
Registered · 2026-09-18
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around NRXP.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading NRXP Form 4 filings
Public disclosures

Congress activity in NRXP

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for NRXP in the cached public ledger.

Federal contracts

NRXP contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NRXP in this window.
Lobbying spend

NRXP lobbying filings, year to date.

Registered lobbying filings matched to NRX Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for NRXP in this window.
Loading news for NRXP
Analyst ratings
Sovereign unlock shows live analyst consensus for NRXP.
Options
Sovereign unlock shows live options positioning for NRXP.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.